retatrutide triple hormone receptor agonist metabolic obesity for dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Severe Obesity Trial Shows
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6






















